To determine the composition of the immunopeptidome of CRC, we analyzed a collection of samples comprising four CRC-derived cell lines and six sets of primary adenocarcinoma samples, which consist of matched tumor and NAT (Tables 1 and 2). This evidence concerns the gene BRD2 and adenocarcinoma.